Omada Health reported its quarterly results since its IPO in June. The company’s revenue increased by 49% from $41.21 million to $61 million, with a net loss of $5.31 million, or a 24-cent loss per share. Omada expects full-year revenue between $235 million to $241 million, exceeding analyst expectations of $222 million.

Omada, founded in 2012, offers virtual care programs for chronic conditions like prediabetes and diabetes. The stock opened at $23 in its Nasdaq debut, closing at $19.46 on Thursday. The company finished the second quarter with 752,000 total members, up 52% from the previous year. Omada CEO Sean Duffy credited the company’s performance to capturing tailwinds in cardiometabolic care.

Read more at CNBC: Omada (OMDA) Q2 2025 earnings